West Pharmaceutical Services (WST) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
West Pharmaceutical Services · Health Care · ref. ETF XLV · 50 calls · price $346.09
What the company does: West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
📈 West Pharmaceutical Services (WST) stock price
$346.09+41.0% over range
Aug 28, 25low $230.95 · high $365.74Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
86% recommend buying · 7 analysts
📊 JPI status : West Pharmaceutical Services has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 WST price target & analyst consensus — price $346
The price target · all analysts combined (7 targets)
Highest target · 1 firm of 7$447+29.2%
Median target · of 7 targets$400+15.6%
Lowest target · 1 firm of 7$360+4.0%
Current price$346.09
Where these 7 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
7100%
$360 ↔ $447
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (825 calls tested). It aims for $365 (+5.5 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).
The 4 reliable analysts
$383+11 %
The 3 other firms
$425+23 %
How to read it: the 4 reliable firms are not filtered by optimism — 4 aim above the price, 0 below, hence their $383 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy686%
Hold114%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 WST price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on WST most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in WST? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about West Pharmaceutical Services? The JPI assistant answers using our backtest data.
💰 West Pharmaceutical Services dividend: yield, history & growth › open the full page
0.24%annual yield
🏆 Aristocrat — 33 yrs of consecutive dividend increases
That's ~$0.87 per share per year.
📈 West Pharmaceutical Services fundamentals: valuation, margins & growth › open the full page
P/E 44.8Net margin 17.0 %Revenue growth +13.8 %Fairly valued
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 20 %
2023
Rev +2%Profit +1%
2024
Rev −2%Profit −17%
2025
Rev +6%Profit +0%
🔎 Detailed analyses
✅ Historical analyst reliability on WST
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Wells Fargo ↗ | 100% | +19.6% | 3 |
| Evercore ISI Group ↗ | 100% | +15.2% | 2 |
| Keybanc ↗ | 55% | +6.4% | 11 |
| UBS ↗ | 50% | +5.4% | 2 |
| Jefferies ↗ | 50% | +2.0% | 2 |
| Stephens & Co. ↗ | 33% | -2.7% | 3 |
| B of A Securities ↗ | 29% | -22.8% | 7 |
📊 What $1,000 invested in West Pharmaceutical Services would be worth › open the full page
In short — $1,000 invested in West Pharmaceutical Services 10 years ago would be worth $5,788 today, i.e. +19%/yr on average. Best year: 2020 (+86%), worst: 2024 (-35%). Price performance, excluding dividends.
If I'd invested $1,000 in West Pharmaceutical Services
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,545 | +55% |
| 3 years ago | $1,132 | +13% |
| 5 years ago | $1,279 | +28% |
Return by year (West Pharmaceutical Services)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +41% | $1,411 (+41%) |
| 2025 | +9% | $1,545 (+55%) |
| 2024 | -35% | $1,002 (+0%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on West Pharmaceutical Services
Loading news…
📋 All analyst calls on WST
Filtered on — · ✕ show all
▲ Buy · 🎯$412
Price at call : $348.76 — upside +18%
Today : $346.09 — upside +19%
🎯 on WST : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
Evercore ISI Group ↗
Jul 27, 26
▲ Outperform · 🎯$425
Price at call : $337 — upside +26%
Today : $346.09 — upside +23%
🎯 on WST : 100% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
BNP Paribas
Jul 13, 26
▲ Outperform · 🎯$447
Price at call : $357.65 — upside +25%
Today : $346.09 — upside +29%
🎯 on WST : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
Morgan Stanley ↗
Jul 9, 26
■ Equal-Weight neutral · not a buy · 🎯$365
Price at call : $353.71 — gap to target +3%
Today : $346.09 — gap to target +5%
🎯 on WST : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$410
Price at call : $356.08 — upside +15%
Today : $346.09 — upside +18%
🎯 on WST : 100% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▲ Overweight · 🎯$390
Price at call : $365.74 — upside +7%
Today : $346.09 — upside +13%
🎯 on WST : 56% (9 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
in progress (365j)
matures : Jul 2, 27
matures : Jul 2, 27
▲ Overweight · 🎯$400
Price at call : $334.66 — upside +20%
Today : $346.09 — upside +16%
🎯 on WST : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jun 9, 27
matures : Jun 9, 27
Stephens & Co. ↗
Jun 2, 26
▲ Overweight · 🎯$360
Price at call : $312.17 — upside +15%
Today : $346.09 — upside +4%
🎯 on WST : 33% (3 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
in progress (365j)
matures : Jun 2, 27
matures : Jun 2, 27
See the other 42 calls, newest to oldest
Morgan Stanley ↗
May 29, 26
■ Equal-Weight neutral · not a buy · 🎯$325
Price at call : $316.3 — gap to target +3%
Today : $346.09 — gap to target -6%
🎯 on WST : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : May 29, 27
matures : May 29, 27
■ Equal-Weight neutral · not a buy · 🎯$310
Price at call : $292.13 — gap to target +6%
Today : $346.09 — gap to target -10%
🎯 on WST : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
■ Equal-Weight neutral · not a buy · 🎯$275
Price at call : $266.5 — gap to target +3%
Today : $346.09 — gap to target -21%
🎯 on WST : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
■ Equal-Weight neutral · not a buy · 🎯$265
Price at call : $243.19 — gap to target +9%
Today : $346.09 — gap to target -23%
🎯 on WST : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
Evercore ISI Group ↗
Feb 3, 26
▲ Outperform · 🎯$320
Price at call : $230.95 — upside +39%
Today : $346.09 — upside -8%
🎯 on WST : 100% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
Morgan Stanley ↗
Dec 2, 25
■ Equal-Weight neutral · not a buy · 🎯$285
Price at call : $284.31 — gap to target +0%
Today : $346.09 — gap to target -18%
🎯 on WST : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
▲ Buy · 🎯$350
Price at call : $284.86 — upside +23%
Today : $346.09 — upside +1%
🎯 on WST : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
■ Equal-Weight neutral · not a buy · 🎯$325
Price at call : $283.49 — gap to target +15%
Today : $346.09 — gap to target -6%
🎯 on WST : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
▲ Buy · 🎯$355
Price at call : $287.22 — upside +24%
Today : $346.09 — upside +3%
🎯 on WST : 50% (2 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Oct 24, 26
matures : Oct 24, 26
▲ Overweight · 🎯$350
Price at call : $297.47 — upside +18%
Today : $346.09 — upside +1%
🎯 on WST : 56% (9 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
in progress (365j)
matures : Oct 24, 26
matures : Oct 24, 26
Evercore ISI Group ↗
Oct 23, 25
▲ Outperform · 🎯$390
Price at call : $297.47 — upside +31%
Today : $346.09 — upside +13%
🎯 on WST : 100% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
■ Equal-Weight neutral · not a buy · 🎯$275
Price at call : $273.16 — gap to target +1%
Today : $346.09 — gap to target -21%
🎯 on WST : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 2, 26
matures : Oct 2, 26
Rothschild & Co
Sep 15, 25
▲ Buy · 🎯$311
Price at call : $258.35 — upside +20%
Today : $346.09 — upside -10%
🎯 on WST : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 15, 26
matures : Sep 15, 26
▲ Buy · 🎯$320
Price at call : $257.76 — upside +24%
Today : $346.09 — upside -8%
Expected +24% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on WST : 50% (2 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
+28.5%
stock +29% · XLV +21%
matured Jul 25, 26
Evercore ISI Group ↗
Jul 25, 25
▲ Outperform · 🎯$350
Price at call : $257.76 — upside +36%
Today : $346.09 — upside +1%
Expected +36% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on WST : 100% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+28.5%
stock +29% · XLV +21%
matured Jul 25, 26
■ Equal-Weight neutral · not a buy · 🎯$260
Price at call : $263.51 — gap to target -1%
Today : $346.09 — gap to target -25%
🎯 on WST : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jul 25, 26
matures : Jul 25, 26
■ Equal-Weight neutral · not a buy · 🎯$245
Price at call : $222.68 — gap to target +10%
Today : $346.09 — gap to target -29%
🎯 on WST : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jun 24, 26
matures : Jun 24, 26
Evercore ISI Group ↗
Mar 18, 25
▲ Outperform · 🎯$275
Price at call : $234.47 — upside +17%
Today : $346.09 — upside -21%
Expected +17% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on WST : 100% (2 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+1.9%
stock +2% · XLV +0%
matured Mar 18, 26
▲ Overweight · 🎯$325
Price at call : $211 — upside +54%
Today : $346.09 — upside -6%
Expected +54% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on WST : 56% (9 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
+15.3%
stock +15% · XLV +9%
matured Feb 14, 26
▲ Buy · 🎯$400
Price at call : $331.73 — upside +21%
Today : $346.09 — upside +16%
Expected +21% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on WST : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
-16.9%
stock -17% · XLV +13%
matured Jan 8, 26
B of A Securities ↗
Dec 13, 24
▲ Buy · 🎯$355
Price at call : $330.57 — upside +7%
Today : $346.09 — upside +3%
Expected +7% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on WST : 33% (3 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
-17.8%
stock -18% · XLV +12%
matured Dec 13, 25
Wolfe Research ↗
Dec 13, 24
■ Peer Perform neutral · not a buy
🎯 on WST : no call matured yet · 📊 on Health : 60.9% · +4.3% (46 calls)
in progress (365j)
matures : Dec 13, 25
matures : Dec 13, 25
▲ Buy · 🎯$390
Price at call : $330.05 — upside +18%
Today : $346.09 — upside +13%
Expected +18% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on WST : 50% (2 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
-17.6%
stock -18% · XLV +11%
matured Dec 12, 25
■ Neutral neutral · not a buy · 🎯$375
Price at call : $350.18 — gap to target +7%
Today : $346.09 — gap to target +8%
🎯 on WST : 50% (2 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 15, 25
matures : Feb 15, 25
▲ Overweight · 🎯$470
Price at call : $398.59 — upside +18%
Today : $346.09 — upside +36%
Expected +18% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on WST : 56% (9 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
-19.1%
stock -19% · XLV +2%
matured Feb 12, 25
▲ Buy · 🎯$536
Price at call : $413 — upside +30%
Today : $346.09 — upside +55%
Expected +30% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on WST : 0% (1 call matured) · 📊 on Health : 50.8% · +4.5% (380 calls)
-20.0%
stock -20% · XLV +2%
matured Feb 6, 25
Stephens & Co. ↗
Oct 27, 23
▲ Overweight · 🎯$390
Price at call : $319.86 — upside +22%
Today : $346.09 — upside +13%
Expected +22% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on WST : 33% (3 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-2.9%
stock -3% · XLV +20%
matured Oct 26, 24
▲ Overweight · 🎯$440
Price at call : $409.12 — upside +8%
Today : $346.09 — upside +27%
Expected +8% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on WST : 56% (9 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
-23.1%
stock -23% · XLV +16%
matured Aug 29, 24
▲ Overweight · 🎯$415
Price at call : $392.68 — upside +6%
Today : $346.09 — upside +20%
Expected +6% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on WST : 56% (9 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
-23.8%
stock -24% · XLV +16%
matured Aug 20, 24
▲ Overweight · 🎯$385
Price at call : $365.46 — upside +5%
Today : $346.09 — upside +11%
Expected +5% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on WST : 56% (9 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
-21.2%
stock -21% · XLV +11%
matured Jul 27, 24
Stephens & Co. ↗
Jul 17, 23
▲ Overweight · 🎯$420
Price at call : $384.59 — upside +9%
Today : $346.09 — upside +21%
Expected +9% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on WST : 33% (3 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-15.0%
stock -15% · XLV +14%
matured Jul 16, 24
B of A Securities ↗
Jun 16, 23
▲ Buy · 🎯$405
Price at call : $362.04 — upside +12%
Today : $346.09 — upside +17%
Expected +12% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on WST : 33% (3 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
-7.2%
stock -7% · XLV +10%
matured Jun 15, 24
Stephens & Co. ↗
Apr 11, 23
▲ Overweight · 🎯$400
Price at call : $354.81 — upside +13%
Today : $346.09 — upside +16%
Expected +13% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on WST : 33% (3 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+9.8%
stock +10% · XLV +6%
matured Apr 10, 24
▲ Overweight · 🎯$375
Price at call : $313.72 — upside +20%
Today : $346.09 — upside +8%
Expected +20% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on WST : 56% (9 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
+11.6%
stock +12% · XLV +10%
matured Feb 17, 24
Deutsche Bank ↗
Dec 14, 22
■ Hold neutral · not a buy · 🎯$250
Price at call : $243.58 — gap to target +3%
Today : $346.09 — gap to target -28%
🎯 on WST : no call matured yet · 📊 on Health : 53.3% · +4.5% (291 calls)
in progress (365j)
matures : Dec 14, 23
matures : Dec 14, 23
▲ Overweight · 🎯$315
Price at call : $244.35 — upside +29%
Today : $346.09 — upside -9%
Expected +29% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on WST : 56% (9 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
+43.6%
stock +44% · XLV -6%
matured Dec 2, 23
■ Neutral neutral · not a buy · 🎯$250
Price at call : $234.66 — gap to target +7%
Today : $346.09 — gap to target -28%
🎯 on WST : 50% (2 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Nov 30, 23
matures : Nov 30, 23
B of A Securities ↗
Oct 28, 22
■ Neutral neutral · not a buy · 🎯$250
Price at call : $225.51 — gap to target +11%
Today : $346.09 — gap to target -28%
🎯 on WST : 33% (3 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Oct 28, 23
matures : Oct 28, 23
▲ Overweight · 🎯$350
Price at call : $225.51 — upside +55%
Today : $346.09 — upside +1%
Expected +55% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on WST : 56% (9 calls matureds) · 📊 on Health : 44.1% · -1.7% (143 calls)
+41.8%
stock +42% · XLV -7%
matured Oct 28, 23
Stephens & Co. ↗
Jul 29, 22
■ Equal-Weight neutral · not a buy · 🎯$345
Price at call : $343.56 — gap to target +0%
Today : $346.09 — gap to target -0%
🎯 on WST : 33% (3 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
in progress (365j)
matures : Jul 29, 23
matures : Jul 29, 23
B of A Securities ↗
Apr 29, 22
▲ Buy · 🎯$410
Price at call : $315.06 — upside +30%
Today : $346.09 — upside +18%
Expected +30% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on WST : 33% (3 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
+16.2%
stock +16% · XLV +3%
matured Apr 29, 23
Frequently asked questions
Should I buy West Pharmaceutical Services stock?
This isn't buy advice. For West Pharmaceutical Services, the analyst consensus is "Buy", with an average price target of $400 (+16% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on West Pharmaceutical Services). We show the numbers — you decide.
Is it too late to buy West Pharmaceutical Services? How high can it go?
The most bullish analyst target on West Pharmaceutical Services is $447 (+29% above today's price); the average is $400. That's the upside they see. Check how reliable those analysts have actually been on West Pharmaceutical Services on our site before trusting it.
Is West Pharmaceutical Services still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 7 analysts have a real record on West Pharmaceutical Services, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in West Pharmaceutical Services? The case for and against
The arguments for and against, one by one, from the numbers: why invest in WST (and why hesitate).
What has West Pharmaceutical Services's past performance been?
Historical returns and a "how much if I had invested" calculator: WST performance & returns.
Does West Pharmaceutical Services pay a dividend?
Yield, consistency and growth history of the dividend: WST's dividend.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX